(Q36599098)

15 August 2017

Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industry (English)

1 reference

15 August 2017

0 references

K Bloor

1

1 reference

15 August 2017

A Maynard

series ordinal

2

1 reference

15 August 2017

N Freemantle

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 July 1996

1 reference

15 August 2017

1 reference

15 August 2017

313

1 reference

15 August 2017

7048

1 reference

15 August 2017

33-35

1 reference

New developments in pricing and drug reimbursement in France

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351415

Economic impact of cost-containment strategies in third party programmes in the US (part I).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351415

Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351415

International pharmaceutical spending controls: France, Germany, Sweden, and the United Kingdom

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351415

Promoting cost effective prescribing

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351415

Recent public policies in The Netherlands to control pharmaceutical pricing and reimbursement.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351415

A comparative analysis of the pharmaceutical market in four European countries

20 September 2018

1 reference

12 December 2020

Pricing and reimbursement of pharmaceuticals in Sweden

1 reference

12 December 2020

The German health care system at the crossroads

1 reference

12 December 2020

Regulations controlling costs of drugs: a perspective from the US

1 reference

12 December 2020

The pharmaceutical industry and health reform: lessons from Europe

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.313.7048.33

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

8664771

1 reference